Reduced chemo dose hurts chances for cure in non-Hodgkin's patients

09/21/2004 | USA Today

Patients often avoid the chemotherapy recommended for aggressive, but possibly curable, non-Hodgkin's lymphoma because of severe side effects, thereby hurting their chances of a successful outcome, a study reveals. One of the major side effects that prompted the dose reduction was a drop in the number of white blood cells, which leaves cancer patients open to infections.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA